News on technologies and applications for point-of-care testing.
PartoSure includes a noninvasive strip test that detects placental alpha microglobulin in patients and is already being used in 35 countries in Europe, the Middle East, Asia, and Latin America.
The firm plans to eventually market a direct-from-blood platform that uses infrared spectrometry to identify drug-resistant pathogens within 20 minutes.
Pivoting from a technology that it deemed wasn't robust enough, Confer Health is now designing a platform to enable broad-scale testing at home.
The firm said that it expects to log $500 million in revenues from its Alere rapid diagnostics business in the second quarter.
Patients can perform urinalysis at home using Healthy.io's smartphone-based kit, which immediately sends the data to a database for clinical interpretation.
